Regenerative medicine

Regenerative medicine is an innovative health breakthrough that revolutionizes the current medical practice. It deals with the development of novel therapeutic treatments appropriately tailored to patients with chronic and devastating conditions as well as unmet medical needs. Disruptive regenerative therapies are willing to exceed the alleviation of both the diseases and their related traits by rebuilding health. As the highest prevalence of chronic diseases is noticed in aged population, Morocco is improving its healthcare systems to also fit well with the needs of its elderly people. Moroccan Society for Regenerative Therapies (MSRT), is a distinctive and non-profit organization of Moroccan physicians, biomedical researchers, technologists, healthcare industrials and regulators, created in 2023. MSRT envisions to establish a favorable space that efficiently advances scientific and clinical knowledge on those innovative therapeutic strategies and to foster their optimal translation for Moroccan patients.

Mission

To promote an efficient development of regenerative therapies for a safer human application.

Vision

To actively participate in the advancement of Moroccan healthcare system via an effective development of innovative therapeutics.

Strategy

• Enabling an effective culture of excellence in the field of regenerative therapies both at the research and innovation levels ;
• Actively empowering education on innovative and novel therapeutic strategies, an undoubtable condition to improve the skill knowledge and attitude of health care professionals and the services provided to patients ;
• Supporting the resolution of regulatory, ethical and guideline barriers for an uppermost quality of care to patients with unmet medical needs.

Goals

1. Promotion of research field on regenerative therapies in Morocco ;
2. Communication support and dissemination of knowledge for students, patient associations, and other involved organizations ;
3. Enabling a strategic connection between academics, clinicians, regulators and industrials for an effective translation of regenerative therapies ;
4. Active support in the establishment of a suitable regulatory landscape for regenerative therapies ;
5. Submission of scientific and clinical recommendations related to Regenerative therapies.